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Recanalization of an Occluded
Intrahepatic Portosystemic Covered Stent
via the Percutaneous Transhepatic
Approach
A 41-year-old woman with liver cirrhosis had recurrent portal hypertension and
bleeding from esophageal varices due to complete occlusion of a previously
inserted transjugular intrahepatic portosystemic shunt stent. Because recanaliza-
tion of the stent by the transjugular approach was unsuccessful, ultrasound-guid-
ed entry to the splenic vein and portal vein was used. After catheter-directed
intrathrombus thrombolysis, successful opening of the stent was achieved and a
stent was placed. We herein report a rare case in which thrombolysis and
recanalization of a TIPS stent were performed via a percutaneous transhepatic
approach.
ransjugular intrahepatic portosystemic shunt (TIPS) is now considered the
procedure of choice for managing portal hypertension and variceal
bleeding, and especially in patients who are not candidates for surgery
(1). TIPS has shown a 90% success rate for decompressing the portal circulation (2, 3).
However, stent dysfunction is one of the major drawbacks of TIPS, and this raises
concerns regarding its use. The weakness of the TIPS procedure is the frequent need
for endovascular reintervention to ensure stent patency. When it is required, recanal-
ization is typically performed via a transjugular approach. Yet this technique is not
always successful. We report here a rare case in which recanalization and thrombolysis
of a TIPS stent were performed through a transhepatic approach.
CASE REPORT
A 41-year-old woman with a history of liver cirrhosis presented with recurrent
portal hypertension and bleeding from esophageal varices. Three months prior to this
admission, a TIPS was created with a 10 mm × 7 cm Wallgraft (Boston Scientific,
Natick, MA). However, the stent’s anticoagulation was inadequate (international
normalized ratio [INR]: 1.02-1.21) after placement. The Doppler ultrasonography on
admission revealed complete occlusion of the stent.
The initial attempts at recanalization of the completely occluded stent via the
transjugular approach were unsuccessful. Therefore, a percutaneous transsplenic
approach guided by ultrasound was used to gain entry to the splenic vein and portal
vein for catheterization of the occluded stent. To perform the ultrasound guided
puncture of the splenic vein through the spleen, we used a Skater
� Introducer set
(Angiotech, PBN Medicals, Denmark). A 22-guage Chiba needle was introduced into
the splenic vein, then a 0.018 inch guide wire was placed through the Chiba needle
into the splenic vein, and a 6-Fr dilator system was placed over the wire. We then
exchanged the 0.018 inch guide wire with a 0.035 inch guide wire, followed by a 5-Fr
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Tintroducer sheath and a 4-Fr KMP catheter (Cook Medical
Inc., Bloomington, IN). However, residual thrombosis of
the stent was noted in combination with occlusion of the
hepatic vein (Fig. 1A, B). So, we performed catheter-
directed intrathrombus thrombolysis with urokinase
(Taiwan Green Cross Co., Taipei, Taiwan). In brief, the
distal end of a 4 Fr RC1 catheter (Cook Medical Inc.,
Bloomington, IN) with home-made side holes (n = 10,
made by needle-sticks into the distal 5-cm segment of the
catheter) was wedged into the thrombosed TIPS stent.
Then, catheter-directed intrathrombus thrombolysis with a
solution of 48 vials of Urokinase (60,000 U/vial) in 500
mL normal saline at a drip rate of 21 mL/hr (i.e., 2 vials/hr
= 2,000 U/kg/hr) was administered for 24 hours.
Recanalization was performed in the following day and a
Wallstent endoprosthesis (14 mm × 9 cm, Boston
Scientific, Natick, MA) was placed, resulting in the success-
ful opening of the shunt (Fig. 1C-E). The catheters were
removed and the transsplenic tract was embolized with 4
serial coils (MWCE-35-8/4-Tornado, Cook Medical Inc.,
Bloomington, IN), as shown in Figure 1F.
The patient recovered uneventfully without significant
splenic bleeding. She was discharged eight days after
recanalization. The evaluation by ultrasonography showed
the stent was  patent. The patient’s warfarin dosage was
adjusted and her INR on discharge was 1.92. She is doing
well five months after discharge and an ultrasound study
indicates that the stent remains patent.
Chan et al.
470 Korean J Radiol 11(4), Jul/Aug 2010
ABC
Fig. 1. Recanalization of occluded intrahepatic portosystemic covered stent.
A. Direct portography performed from transsplenic catheter showed occluded intrahepatic portosystemic covered stent. Superior
mesenteric vein filled in retrograde direction and gastric collaterals were also observed. 
B. With advancing catheter into covered stent, incomplete recanalization was obvious with residual thrombosis and outflow hepatic
venous occlusion. 
C. Wire was successfully negotiated through hepatic vein into caval vein. 
D. New stent placed through covered stent (arrow) and hepatic vein into caval vein. 
E. Portography at completion of procedure showed that shunt is now patent. 
F. Coil embolization of transplenic tract upon removal of final sheath. Subcapsular lining of spleen (arrow) and tip of sheath are observed.
DEFDISCUSSION
Transjugular intrahepatic portosystemic shunt is now
considered the procedure of choice for accessing the portal
system for management of refractory variceal bleeding.
Certain complications, including a high reintervention rate
due to occlusion of the stent, have raised concerns regard-
ing its application (2, 3). Yet recent reports have suggested
that using a covered prosthesis improves the TIPS patency
to longer than two years (4, 5).
Although a covered stent had been employed in the
patient presented here, thrombosis occurred early (i.e.,
within 3 months). Recanalization was necessary, but the
transjugular approach could not be used.
Transjugular intrahepatic portosystemic shunt failure
requires recanalization of the stent or placement of serial
or parallel stents (6, 7). Neointimal hyperplasia at the ends
of the stent may completely occlude the outflow hepatic
venous tract (1) and this can make reintervention difficult.
As in this case, an alternative route is needed when
attempts at recanalization via a conventional transjugular
approach fail.
The splenic vein drains directly to the portal vein, and its
size and straight route make this approach an ideal option
(5, 8). In addition, this route provides the requisite forces
for handling wires and catheters. The transsplenic
approach has been used for other indications, as reviewed
by Tuite et al. (8), but we are unaware of any other report
of using the percutaneous transsplenic approach to recanal-
ize an occluded TIPS stent. Additionally, we believe that
the overnight infusion of a thrombolytic agent contributed
to successful recanalization in our case (9).
Concerns regarding post-procedural splenic bleeding and
the reported difficulty some clinicians have experienced
negotiating the pathway have limited the use of the transs-
plenic route. A cautious, image-guided approach reduces
the risk of splenic hemorrhage (5, 8) and obliteration of the
transsplenic tract with coils upon completion of the
procedure also assists in preventing post-procedural
bleeding (8). No significant splenic bleeding occurred in
our patient, despite her liver impairment, during or follow-
ing the intervention.
Subtherapeutic anticoagulation (INR < 2) probably
contributed to the thrombosis and subsequent occlusion in
this patient. There is no routine anticoagulation protocol to
follow for TIPS patients. We prescribe anticoagulation for
only the patients with TIPS dysfunction; however, there is
no reference available for the effectiveness of this regime.
As a general rule for preventing thromboembolism,
chronic oral anticoagulant therapy with a vitamin K
antagonist is administered and the dose is adjusted to
achieve an INR of 2.0 to 3.0 (10).
In summary, we have reported on a rare case of using
the transsplenic approach for recanalization of a TIPS stent
by thrombolysis. Transsplenic entry to the portal system is
useful in recanalizing a stent that is difficult to reach
through the usual transjugular route.
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